Dose escalation/expansion study to investigate the safety, pharmacokinetics, food effect, and antitumor activity of BGB-290 in patients with advanced solid tumors

J. Lickliter; L. Mileshkin; M. Voskoboynik; M. Millward; A. Freimund; T. Meniawy; T. Tang; R. Wei; M. Li; V. Paton

Dose escalation/expansion study to investigate the safety, pharmacokinetics, food effect, and antitumor activity of BGB-290 in patients with advanced solid tumors

J. Lickliter, L. Mileshkin, M. Voskoboynik, M. Millward, A. Freimund, T. Meniawy, T. Tang, R. Wei, M. Li, V. Paton

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

5 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Annals of Oncology
Volume	28
Publication status	Published - Sept 2017
Event	42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sept 2017 → 12 Sept 2017

Cite this

@article{304ac589d11c4ca0b14abe8eb893c14a,

title = "Dose escalation/expansion study to investigate the safety, pharmacokinetics, food effect, and antitumor activity of BGB-290 in patients with advanced solid tumors",

author = "J. Lickliter and L. Mileshkin and M. Voskoboynik and M. Millward and A. Freimund and T. Meniawy and T. Tang and R. Wei and M. Li and V. Paton",

year = "2017",

month = sep,

language = "English",

volume = "28",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "42nd European-Society-for-Medical-Oncology Congress (ESMO) ; Conference date: 08-09-2017 Through 12-09-2017",

}

TY - JOUR

T1 - Dose escalation/expansion study to investigate the safety, pharmacokinetics, food effect, and antitumor activity of BGB-290 in patients with advanced solid tumors

AU - Lickliter, J.

AU - Mileshkin, L.

AU - Voskoboynik, M.

AU - Millward, M.

AU - Freimund, A.

AU - Meniawy, T.

AU - Tang, T.

AU - Wei, R.

AU - Li, M.

AU - Paton, V.

PY - 2017/9

Y1 - 2017/9

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 28

JO - Annals of Oncology

JF - Annals of Oncology

T2 - 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Y2 - 8 September 2017 through 12 September 2017

ER -